glp-1 dementia news Can popular diabetes and weight-loss drugs slow vascular dementia? GLP-1 receptor agonists show promise

We hear all the time that our patients stopped thinking about food. GLP-1 agonists were really developed initially for the treatment of diabetes, but it became apparent pretty quickly that they can also cause weight loss, he says

Endocrinologists viewed their ideal patient as an individual with established cardiovascular disease or high cardiovascular risk, including those with diabetic kidney disease, who are already being treated with more than one oral medication (including either SGLT2is or GLP1-RAs) and an HbA1c level exceeding the established target

Injection site used

GLP-1s can suppress thirst as well as hunger, so its easy to get behind on fluids